Key result
Intramyocardial hemorrhage ≥1.0% of LV mass is linked to ~14% higher death and HF hospitalization risk.
Why the study?
Optimal IMH detection with T2 mapping is limited by artifact sensitivity and long acquisition times, prompting evaluation of the prognostic value of IMH identified by conventional T2-weighted imaging in STEMI.
Does quantitative intramyocardial hemorrhage assessment by conventional T2-weighted imaging improve risk stratification in reperfused STEMI patients?
Cohort (n=453)
No
Does quantitative intramyocardial hemorrhage assessment by conventional T2-weighted imaging improve risk stratification in reperfused STEMI patients?
Quantitative intramyocardial hemorrhage assessment using conventional T2-weighted imaging provides significant incremental prognostic value beyond traditional risk factors in reperfused STEMI patients.
Answers are grounded in this paper and cite their sources.
May refine post-STEMI risk stratification on routine T2-weighted CMR; hypothesis-generating and requires prospective validation before practice change.
Intramyocardial hemorrhage (IMH), a severe reperfusion injury, is optimally detected by T2* mapping, which remains limited by sensitivity to artifacts and relatively long acquisition times. We aimed to evaluate the prognostic value of IMH identified by conventional T2-weighted (T2W) imaging in patients with ST-elevation myocardial infarction (STEMI). In this single-center retrospective study, 453 STEMI patients underwent CMR at a median of 5 days post-reperfusion. IMH was identified quantitatively as a hypointense core within edema on T2W imaging and expressed as a percentage of left ventricular mass. The primary endpoint was a composite of all-cause death and heart failure hospitalization. IMH was present in 167 patients (36.9%). Over a median follow-up of 25 months, 49 patients (10.8%) experienced MACE. Those with MACE had a higher prevalence of IMH (75.5% vs. 32.2%, p < 0.001). Multivariable Cox regression identified IMH extent ≥ 1.0% of LV mass as a strong and independent predictor of MACE (HR 1.14, 95% CI 1.07-1.21, p < 0.001). Adding quantitative IMH to a base model (anterior infarction, IS, MVO, LVEF) significantly improved prognostic performance: AUC increased from 0.800 to 0.828, with net reclassification improvement of 12% (p < 0.001) and integrated discrimination improvement of 7% (p = 0.018). In this selected cohort, quantitative IMH assessment using conventional T2W imaging provides significant incremental prognostic value beyond traditional risk factors in STEMI patients, enabling improved risk stratification with a widely available CMR sequence.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=453). Intramyocardial hemorrhage (IMH) extent ≥ 1.0% of LV mass on T2-weighted imaging vs. Absence of IMH or IMH extent < 1.0% of LV mass was evaluated on Composite of all-cause death and heart failure hospitalization (HR 1.14, 95% CI 1.07-1.21, p=<0.001). Quantitative intramyocardial hemorrhage extent ≥1.0% of LV mass on T2-weighted imaging independently predicted all-cause death and heart failure hospitalization (HR 1.14; 95% CI 1.07-1.21; p<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: